N-803 Plus Nivolumab for Advanced or Metastatic Non-Small Cell Lung Cancer: Update on Phase II Experience of Combination PD1 Blockade with an IL-15 Superagonist

Category Primary study
JournalJournal of Thoracic Oncology
Year 2020
This article has no abstract
Epistemonikos ID: fec0ea5f7dca6b1917b65cff6d997c4adc3e7b2c
First added on: Feb 11, 2025